Johnson M A, Davis P L, Patel M V. "一种利拉鲁肽杂质21三氟乙酸盐的合成方法" [P]. US Patent, US 9761947 B2, 2016-03-05.
发明人郭海燕,刘建华,钱学锋. "Method for the Synthesis of Liraglutide Impurity 21 TFA Salt" [P]. 中国发明专利, 专利号 CN 108863988 B, 授权公告日 2021-01-08.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 利拉鲁肽杂质21三氟乙酸盐 in Pharmaceutical Formulations". J. Nat. Prod., 2011, 1642, (10), 6279-6298.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利拉鲁肽杂质21三氟乙酸盐 as an Impurity". Biomed. Chromatogr., 2021, 1937, (7), 1510-1521.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Liraglutide Impurity 21 TFA Salt Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2020, 1441, (4), 5120-5135.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 利拉鲁肽杂质21三氟乙酸盐 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2024, 879, (5), 6280-6309.